Telehealth-based group breathing intervention for adults with chronic pain: A randomized controlled trial.

Not Applicable

Recruiting

• Conditions: Chronic pain; Musculoskeletal - Other muscular and skeletal disorders; Physical Medicine / Rehabilitation - Speech therapy; Anaesthesiology - Pain management; Mental Health - Depression; Mental Health - Anxiety

• Registration Number: ACTRN12623000393651
• Lead Sponsor: niversity of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-18
• Last Update Posted: 9 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

•Patients with non-malignant chronic pain for >3 months confirmed by a medical practitioner or chronic pain specialist.
•18 years or above,
•moderately depression or moderately anxiety on DASS21
•Moderate pain severity defined as an average severity score of 5 or more on the Brief Pain Inventory
•Have access to stable internet connection and electronic device with teleconferencing capabilities or able to travel to Western NSW Health Community Health Centre to access telehealth facilities,
•Sufficient English skills to participate in the group intervention and interview.

Exclusion Criteria

•Individuals with spinal cord injury,
•Have a history of central nervous system diseases such as stroke, multiple sclerosis,
•Have known cognitive impairment and impaired memory that will preclude participation,
•Individuals who are currently participating in self-management or other intervention that emphasizes on breathing techniques such as yoga, and meditation,
•Have previous exposure to breathing training programs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression measured by the Depression Anxiety Stress Scale - 21 items (DASS-21)[ Baseline, 4 weeks post-initiation of treatment, 8 weeks post-initiation of treatment (primary endpoint), and 6 months post-initiation of treatment.];Anxiety measured by the Depression Anxiety Stress Scale - 21 items (DASS-21)[ Baseline, 4 weeks post-initiation of treatment, 8 weeks post-initiation of treatment (primary endpoint), and 6 months post-initiation of treatment.];Stress measured by the Depression Anxiety Stress Scale - 21 items (DASS-21)[ Baseline, 4 weeks post-initiation of treatment, 8 weeks post-initiation of treatment (primary endpoint), and 6 months post-initiation of treatment.]

Secondary Outcome Measures

Name	Time	Method
Pain measured by with the Brief Pain Inventory[ Baseline, 4 weeks post-initiation of treatment, 8 weeks post-initiation of treatment, and 6 months post-initiation of treatment.];Pain Catastrophising will be measured with the Pain Catastrophizing Scale.[ Baseline, 4 weeks post-initiation of treatment, 8 weeks post-initiation of treatment, and 6 months post-initiation of treatment.];The level of confidence a person has on his or her ability to participate in a range of activities despite their pain will be measured The Pain Self-Efficacy Questionnaire (PSEQ).[ Baseline, 4 weeks post-initiation of treatment, 8 weeks post-initiation of treatment, and 6 months post-initiation of treatment.]